Table 1.
Patient and tumour characteristics ( n =192)
| Variables | No (%) |
|---|---|
| Age (years) | |
| Median (range) | 62 (36–87) |
| Menopausal status | |
| Premenopausal | 48 (26) |
| Postmenopausal | 138 (74) |
| Unknown | 6 |
| Type of surgery | |
| BCSa (no ALNDb) | 4 (2) |
| BCS + ALND | 36 (19) |
| Mastectomy (no ALND) | 7 (4) |
| Mastectomy + ALND | 145 (76) |
| Tumour size (mm) | |
| pT1 (≤20) | 108 (57) |
| pT2 (>20 and ≤50) | 69 (37) |
| pT3 (>50) | 12 (6) |
| Undefined | 3 |
| Nodal status c | |
| pN- (ALND) | 106 (59) |
| cN- (no ALND) | 11 |
| pN+ | 75 (41) |
| pN1 (1-3+) | 36 (20) |
| pN2 (4-9+) | 28 (16) |
| pN3 (>9+) | 11 (6) |
| Pathological stage d | |
| I | 78 (42) |
| II | 68 (36) |
| III | 42 (22) |
| IV | 0 (0) |
| Undefined (but not stage IV) | 4 |
| Adjuvant therapy e | |
| RT (total) | 93 (48) |
| CT (total) | 5 (3) |
| ET (total) | 78 (41) |
| RT (monotherapy) | 39 (20) |
| CT (monotherapy) | 3 (12) |
| ET (monotherapy) | 27 (14) |
| RT+CT | 3 (2) |
| RT+ET | 51 (27) |
| CT+ET | 0 (0) |
| RT+CT+ET | 0 (0) |
aBCS: Breast conserving surgery.
bALND: Axillary lymph node dissection.
cc = clinical, p = pathological, N- = node negative, N+ = node positive.
dPathological stage: I = pT1-2N0M0, II = T2-3N0, M0 T1-2N1M0,
III = pT3N1M0, pT1-3N2M0, T4N0-2M0, T1-4N3M0,
IV = T1-4N0-3M1.
eAdjuvant therapy: RT = radiotherapy, CT = chemotherapy, ET = endocrine therapy.